PFS
DNA icon

Prospera Financial Services’s Ginkgo Bioworks DNA Stock Holding History

Prospera Financial Services’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-31
Closed -$3K – 1018
2022
Q2 		$3K Sell
31
-1
-3% -$122 ﹤0.01% 1507
2022
Q1 		$5K Buy
+32
New +$6.23K ﹤0.01% 2258

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Prospera Financial Services's DNA Position: Q3 2022 in Review

Prospera Financial Services sold out of Ginkgo Bioworks (DNA) in Q3 2022, closing a stake of 31 shares — an estimated $3K sold.

Prospera Financial Services first reported a position in DNA in Q1 2022 and held it in 2 quarters. The position peaked at $5K in Q1 2022. 278 funds tracked by Wall St. Rank hold DNA as of Q3 2022.

  • Prospera Financial Services reported no remaining Ginkgo Bioworks position as of Q3 2022 after selling out during the quarter.
  • Prospera Financial Services sold 31 Ginkgo Bioworks shares in Q3 2022, an estimated $3K.
  • Prospera Financial Services first reported a position in Ginkgo Bioworks in Q1 2022 and held it in 2 quarters.
  • Prospera Financial Services's Ginkgo Bioworks position peaked at $5K in Q1 2022.
  • 278 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2022.

Based on Prospera Financial Services's 13F filing for Q3 2022, filed 27 Oct 2022.